No earnings forecast score is currently available for Telomir Pharmaceuticals Inc. The Pharmaceuticals industry's average is 7.83. The average price target is 15.50, with a high of 15.50 and a low of 15.50.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Telomir Pharmaceuticals Inc's price target?
Analysts forecast that Telomir Pharmaceuticals Inc's price target is USD 15.50, with the highest forecast at USD 15.50 and the lowest forecast at USD 15.50.
How have Telomir Pharmaceuticals IncTELO's recent earnings per share performed?
The market expectation was USD -0.03, while Telomir Pharmaceuticals IncTELO's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.07.